Evidence map›Paper›PMID 25604774›Full record

ReviewEuropean journal of clinical nutrition2015

The view of European experts regarding health economics for medical nutrition in disease-related malnutrition.

K Freijer, I Lenoir-Wijnkoop, C A Russell, M A Koopmanschap, H M Kruizenga, S K Lhachimi, K Norman, M J C Nuijten, J M G A Schols

Open access · bronzeAbstract readReview
PubMed Publisher
In one paragraph

Review in European journal of clinical nutrition, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 3 countries.

K FreijerSchool for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, The Netherlands.
I Lenoir-WijnkoopDepartment of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
C A RussellTowcester, Northants, UK.
M A KoopmanschapHealth Economics and Health Technology Assessment, Institute for Medical Technology Assessment (iMTA), Institute for Health Policy and Management (iBMG), Erasmus University Rotterdam, Rotterdam, The Netherlands.
H M KruizengaDepartment of Nutrition and Dietetics, Project leader Dutch Malnutrition Steering Group, VU University Medical Centre, Amsterdam, The Netherlands.
S K Lhachimi1] Cooperative Research Group for Evidence-Based Public Health, Department of Prevention and Evaluation, Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany [2] Institute for Public Health, Health Sciences Bremen, University Bremen, Bremen, Germany.
K NormanResearch group Geriatrics, Charité Universitätsmedizin Berlin, Berlin, Germany.
M J C NuijtenArs Accessus Medica Amsterdam, The Netherlands.
J M G A ScholsDepartment of General Practice and Department of Health Services Research, School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, The Netherlands.
Maastricht University · NLAmsterdam UMC Location VUmc · NLCharité - Universitätsmedizin Berlin · DEErasmus University Rotterdam · NLLeibniz Institute for Prevention Research and Epidemiology - BIPS · DEOclaro (United Kingdom) · GBUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Health-care systems are currently facing tremendous budget constraints resulting in growing pressure on decision makers and health-care providers to obtain the maximum possible health benefits of the resources available. Choices have to be made, and health economics can help in allocating limited health-care resources among unlimited wants and needs. Attempts to achieve cost reductions often focus on severe pathologies and chronic diseases as they commonly represent high health-care expenditures. In this context, awareness of the considerable financial burden caused by disease-related malnutrition (DRM) is lacking. Possibilities of reducing costs by optimising the management of DRM through medical nutrition will mostly not even be taken into account. During a European expert meeting, the total evaluation of medical nutrition was viewed and discussed. The aim of this meeting was to gain an experts' outline of the key issues relating to the health economic assessment of the use of medical nutrition. This article provides a summary of the observations per discussed item and describes the next steps suggested.

Indexed as

Cost-Benefit AnalysisEuropeExpert TestimonyHealth ResourcesHealth Services Needs and DemandHumansMalnutritionNutrition Policy

Identifiers

PMID25604774
OpenAlexW1995519909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.